Literature DB >> 16505392

Screening mammography: do women prefer a higher recall rate given the possibility of earlier detection of cancer?

Marie A Ganott1, Jules H Sumkin, Jill L King, Amy H Klym, Victor J Catullo, Cathy S Cohen, David Gur.   

Abstract

PURPOSE: To prospectively survey women undergoing screening mammography to assess their attitudes toward and preference for the level of recall rates given the possibility that an increase in recall rates may result in earlier detection of cancer.
MATERIALS AND METHODS: This HIPAA-compliant survey was performed with an institutional review board-approved protocol. Women who arrived for their routine screening mammographic examination from November 2004 to March 2005 were informed before they consented to participate. The distribution of responses for each survey question was summarized, and proportions for the entire group and different subgroups were computed. The z score statistic was used to assess significant differences between subgroups.
RESULTS: Fifteen hundred seventy anonymized questionnaires were collected; 1171 (75%) were from women between 40 and 59 years of age. Of 1528 respondents, 1486 (97%) believed that a false-positive result would not deter them from continuing with regular screening, and most would have been willing to be recalled more often for either a noninvasive (86% [1308 of 1519 respondents]) or an invasive (82% [1248 of 1515 respondents]) procedure if it might increase the chance of detecting a cancer (if present) earlier. Compared with respondents undergoing their initial screening mammographic examination, women who had undergone at least one prior screening examination reported that they were more likely to continue with screening if they had received a previous false-positive result (P = .02). Women younger than 60 years and those previously recalled were more willing to be called back more often for a noninvasive or, when indicated, an invasive procedure (P < .05).
CONCLUSION: A substantial fraction of women in this study would have preferred the inconvenience of and anxiety associated with a higher recall rate if it resulted in the possibility of detecting breast cancer earlier. Copyright RSNA, 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16505392     DOI: 10.1148/radiol.2383050852

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Recommendations on screening for breast cancer in average-risk women aged 40-74 years.

Authors:  Marcello Tonelli; Sarah Connor Gorber; Michel Joffres; James Dickinson; Harminder Singh; Gabriela Lewin; Richard Birtwhistle; Donna Fitzpatrick-Lewis; Nicole Hodgson; Donna Ciliska; Mary Gauld; Yan Yun Liu
Journal:  CMAJ       Date:  2011-11-22       Impact factor: 8.262

2.  Breast cancer screening.

Authors:  Paula B Gordon
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

3.  Informed decision making before initiating screening mammography: does it occur and does it make a difference?

Authors:  Larissa Nekhlyudov; Rong Li; Suzanne W Fletcher
Journal:  Health Expect       Date:  2008-12       Impact factor: 3.377

4.  Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services.

Authors:  Alexander G Mathioudakis; Minna Salakari; Liisa Pylkkanen; Zuleika Saz-Parkinson; Anke Bramesfeld; Silvia Deandrea; Donata Lerda; Luciana Neamtiu; Hector Pardo-Hernandez; Ivan Solà; Pablo Alonso-Coello
Journal:  Psychooncology       Date:  2019-03-24       Impact factor: 3.894

5.  The "Sweet Spot" Revisited: Optimal Recall Rates for Cancer Detection With 2D and 3D Digital Screening Mammography in the Metro Chicago Breast Cancer Registry.

Authors:  Garth H Rauscher; Anne Marie Murphy; Qiong Qiu; Therese A Dolecek; Katherine Tossas; Yanyang Liu; Nila H Alsheik
Journal:  AJR Am J Roentgenol       Date:  2021-02-10       Impact factor: 3.959

6.  Demographic factors influencing consensus opinion on the recall for women screened by mobile mammography unit in taiwan.

Authors:  Lee Yu-Mei; Yao Hsueh-Hua
Journal:  Iran J Radiol       Date:  2013-08-30       Impact factor: 0.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.